Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Kratom Regulation topic
No spam. Unsubscribe anytime.
Senators pass committee amendments to create Kratom Consumer Protection framework and advance bill
Summary
Lawmakers adopted white‑copy floor amendments to LB230, creating a state product registry, excluding synthesized derivatives and focusing on limiting highly concentrated 7‑hydroxymitragynine products; the bill advanced to E & R initial.
Senator Hallstrom introduced LB230 to create a Kratom Consumer Protection Act that would regulate kratom products sold in Nebraska while trying to keep safe, traditional kratom products available. He described the state’s role as keeping untested and potentially dangerous synthetic or highly concentrated products off the market while allowing properly manufactured, labeled kratom products to remain available.
Committee amendment AM55 narrowed and clarified several provisions, and a subsequent white‑copy floor amendment (AM381) replaced the committee amendment. The adopted language: (1) removes an attestation requirement for 7‑hydroxymitragynine in product labels and instead requires producers to demonstrate alkaloid content at registration, (2) tightens the definition of “synthesized” to capture fully and semi‑synthesized components so those products can be excluded, (3) clarifies that kratom products are not intended for inhalation, (4) creates a product registration process (modeled on other Nebraska registries) that lets producers consolidate applications for the same product sold in different packaging, and (5) defines adulterated products to include products containing kratom alkaloids that do not meet the act’s product definition.
Supporters included the Global Kratom Coalition and the American Kratom Association; proponents stated they favored a regulatory scheme over an outright ban and wanted to keep traditional kratom products on the market while excluding synthetic derivatives that have been associated with severe adverse events. Opponents were not reflected in testimony at committee; the bill reported out of committee 8‑0.
On the floor the body adopted AM381 (white copy) and then AM55 as the committee amendment in sequence; both recorded votes showed unanimous recorded support in the transcript. The bill then advanced to E & R initial.
Outcome: Committee amendment AM55 and white‑copy amendment AM381 were adopted; LB230 advanced to E & R initial.
